Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Key pharmacokinetic data for GHK-Cu: Plasma half-life: Approximately 0.51 hour after intravenous administration
The board-certified health coach assigned at intake adds another clinical interaction, with one-on-one video bookings available in the portal at no extra charge
Native rhIGF-1 (mecasermin, brand name Increlex) is FDA-approved only for the long-term treatment of growth failure in pediatric patients with severe primary IGF-1 deficiency or with GH gene deletion who have developed neutralizing antibodies to GH
dark spots and uneven skin tone
US$ 25.81
US$ 21.18
US$ 28.34
